Tilray Brands Price to Free Cash Flow Ratio 2017-2025 | TLRY
Historical price to free cash flow ratio values for Tilray Brands (TLRY) since 2017.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Tilray Brands Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-05-08 | 0.44 | 0.00 | |
| 2025-02-28 | 0.74 | $-0.08 | 0.00 |
| 2024-11-30 | 1.34 | $-0.09 | 0.00 |
| 2024-08-31 | 1.71 | $-0.09 | 0.00 |
| 2024-05-31 | 1.80 | $-0.07 | 0.00 |
| 2024-02-29 | 1.73 | $-0.05 | 0.00 |
| 2023-11-30 | 1.81 | $-0.05 | 0.00 |
| 2023-08-31 | 2.96 | $0.04 | 83.15 |
| 2023-05-31 | 1.67 | $-0.01 | 0.00 |
| 2023-02-28 | 2.83 | $-0.13 | 0.00 |
| 2022-11-30 | 3.87 | $-0.23 | 0.00 |
| 2022-08-31 | 3.80 | $-0.27 | 0.00 |
| 2022-05-31 | 4.49 | $-0.41 | 0.00 |
| 2022-02-28 | 6.10 | $-0.55 | 0.00 |
| 2021-11-30 | 10.12 | $-0.20 | 0.00 |
| 2021-08-31 | 13.69 | $-0.51 | 0.00 |
| 2021-05-31 | 16.67 | $0.03 | 550.17 |
| 2021-03-31 | 22.73 | $1.01 | 22.60 |
| 2021-02-28 | 24.36 | $-0.01 | 0.00 |
| 2020-12-31 | 8.26 | $0.00 | 0.00 |
| 2020-11-30 | 9.04 | $-1.25 | 0.00 |
| 2020-09-30 | 4.85 | $-2.70 | 0.00 |
| 2020-08-31 | 6.71 | $0.32 | 20.75 |
| 2020-06-30 | 7.11 | $-0.20 | 0.00 |
| 2020-03-31 | 6.88 | $-0.67 | 0.00 |
| 2019-12-31 | 17.13 | $-0.36 | 0.00 |
| 2019-09-30 | 24.74 | $-1.88 | 0.00 |
| 2019-06-30 | 46.56 | $-1.76 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.435B | $0.789B |
| Tilray Brands Inc. is a cannabis-lifestyle and consumer packaged goods company. It operates principally in Canada, the United States, Europe, Australia and Latin America. Tilray Brands Inc., formerly known as Tilray Inc., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.051B | 28.02 |
| Boston Scientific (BSX) | United States | $155.046B | 38.81 |
| Stryker (SYK) | United States | $146.591B | 30.65 |
| EssilorLuxottica (ESLOY) | France | $128.427B | 0.00 |
| Medtronic (MDT) | Ireland | $106.656B | 15.57 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.804B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.530B | 27.59 |
| ResMed (RMD) | United States | $35.880B | 26.95 |
| GE HealthCare Technologies (GEHC) | United States | $31.512B | 14.96 |
| Agilent Technologies (A) | United States | $30.654B | 20.25 |
| Terumo (TRUMY) | Japan | $28.279B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.455B | 16.14 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.623B | 11.96 |
| Insulet (PODD) | United States | $18.597B | 79.37 |
| Baxter (BAX) | United States | $15.765B | 11.77 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.408B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $7.910B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.514B | 22.02 |
| Lantheus Holdings (LNTH) | United States | $5.512B | 14.05 |
| Prestige Consumer Healthcare (PBH) | United States | $4.033B | 19.25 |
| Perrigo (PRGO) | Ireland | $3.604B | 9.20 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.310B | 28.20 |
| Haemonetics (HAE) | United States | $3.228B | 15.19 |
| Envista Holdings (NVST) | United States | $2.854B | 23.72 |
| GN Store Nord (GNNDY) | Denmark | $2.010B | 16.65 |
| LeMaitre Vascular (LMAT) | United States | $1.844B | 41.21 |
| QuidelOrtho (QDEL) | United States | $1.744B | 12.02 |
| AtriCure (ATRC) | United States | $1.500B | 0.00 |
| Neogen (NEOG) | United States | $1.287B | 16.47 |
| Green Thumb Industries (GTBIF) | United States | $1.274B | 28.67 |
| Kestra Medical Technologies (KMTS) | United States | $1.121B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.111B | 11.28 |
| BioLife Solutions (BLFS) | United States | $1.014B | 0.00 |
| InMode (INMD) | Israel | $0.989B | 9.06 |
| Phibro Animal Health (PAHC) | United States | $0.785B | 10.05 |
| Evolus (EOLS) | United States | $0.758B | 0.00 |
| Owens & Minor (OMI) | United States | $0.599B | 5.11 |
| CeriBell (CBLL) | United States | $0.577B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.565B | 0.00 |
| Valneva SE (VALN) | France | $0.551B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.539B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.411B | 0.00 |
| Surmodics (SRDX) | United States | $0.388B | 0.00 |
| Omeros (OMER) | United States | $0.370B | 0.00 |
| SNDL (SNDL) | Canada | $0.342B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.337B | 14.59 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.315B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.287B | 24.23 |
| Verano Holdings (VRNOF) | United States | $0.287B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.283B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.270B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.258B | 45.90 |
| Cerus (CERS) | United States | $0.249B | 0.00 |
| ZimVie (ZIMV) | United States | $0.248B | 14.83 |
| Canopy Growth (CGC) | Canada | $0.237B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.216B | 0.00 |
| Quanterix (QTRX) | United States | $0.208B | 0.00 |
| High Tide (HITI) | Canada | $0.192B | 0.00 |
| Biote (BTMD) | United States | $0.183B | 5.14 |
| Utah Medical Products (UTMD) | United States | $0.177B | 14.27 |
| TriSalus Life Sciences (TLSI) | United States | $0.168B | 0.00 |
| Brainsway (BWAY) | Israel | $0.164B | 51.24 |
| Organigram Global (OGI) | Canada | $0.150B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.149B | 18.39 |
| Jin Medical (ZJYL) | China | $0.126B | 0.00 |
| Exagen (XGN) | United States | $0.123B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.116B | 0.00 |
| MacroGenics (MGNX) | United States | $0.094B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Agape ATP (ATPC) | $0.086B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Fonar (FONR) | United States | $0.076B | 10.70 |
| Veru (VERU) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.073B | 0.00 |
| Zynex (ZYXI) | United States | $0.063B | 0.00 |
| United Health Products (UEEC) | United States | $0.058B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.055B | 0.00 |
| Apyx Medical (APYX) | United States | $0.047B | 0.00 |
| ImmuCell (ICCC) | United States | $0.047B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 56.00 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 11.24 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |